LeMaitre to Present at Upcoming Investor Conferences

LeMaitre Vascular announced its participation in two upcoming investor conferences in May 2021.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

LeMaitre Vascular announced its participation in two upcoming investor conferences in May 2021. David Roberts, President, will present at the 7th Annual Truist Securities Life Sciences Summit on May 4, 2021. He will also be featured at the UBS Global Healthcare Virtual Conference on May 26, 2021, at 9:00 AM EDT. LeMaitre specializes in devices and services for treating peripheral vascular disease, impacting over 200 million people globally. The firm develops vascular devices tailored for vascular surgeons. More information is available at lemaitre.com.

Argus Session date unavailable

+1.81% session move Open Argus

Details

News Market Reaction – LMAT

The recorded move for LMAT in the trading session of this news was +1.81%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

04/27/2021 - 04:23 PM

BURLINGTON, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in May.

David Roberts, President, is scheduled to participate in the 7th Annual Truist Securities Life Sciences Summit on Tuesday, May 4, 2021.

He is also scheduled to present at the UBS Global Healthcare Virtual Conference on Wednesday, May 26, 2021, at 9:00 AM EDT.

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

Contact:
Sandra Millar
LeMaitre Vascular, Inc.
+1-781-425-1686
smillar@lemaitre.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What investor conferences is LeMaitre Vascular participating in May 2021?

LeMaitre Vascular is participating in the 7th Annual Truist Securities Life Sciences Summit on May 4, 2021, and the UBS Global Healthcare Virtual Conference on May 26, 2021.

Who is representing LeMaitre Vascular at the conferences?

David Roberts, the President of LeMaitre Vascular, will represent the company at both conferences.

What is the date and time of LeMaitre's presentation at the UBS Virtual Conference?

LeMaitre's presentation at the UBS Global Healthcare Virtual Conference is scheduled for May 26, 2021, at 9:00 AM EDT.

What does LeMaitre Vascular specialize in?

LeMaitre Vascular specializes in devices, implants, and services for treating peripheral vascular disease.

How many people are affected by peripheral vascular disease globally?

Peripheral vascular disease affects over 200 million people worldwide.

Keep reading

Trending in the feed

RDW

Sophia Space and Redwire Team Up to Advance Orbital Data Center Infrastructure Open the live feed